Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
International Forum of Allergy & Rhinology
|
April 10, 2015
Computer-assisted staging of chronic rhinosinusitis correlates with symptoms
Jonathan Garneau, Michael Ramirez, Samuel G Armato, et al.
Infectious Agents and Cancer
|
February 12, 2009
Fear and loathing in the Caribbean: three studies of fear and cancer screening in Brooklyn's immigrant Caribbean subpopulations
Nathan S Consedine, Brenda A Adjei, David Horton, et al.
Leukemia & Lymphoma
|
November 4, 2020
Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
Jonathan Pan, Sushil Ghimire, S Onder Alpdogan, et al.
Nature Communications
|
February 20, 2016
Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
Michael Ramirez, Satwik Rajaram, Robert J Steininger, et al.
Neoplasia (New York, N.Y.)
|
July 18, 2018
Telomerase-Mediated Strategy for Overcoming Non-Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance
Ilgen Mender, Ryan LaRanger, Krishna Luitel, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
International Forum of Allergy & Rhinology
|
April 10, 2015
Computer-assisted staging of chronic rhinosinusitis correlates with symptoms
Jonathan Garneau, Michael Ramirez, Samuel G Armato, et al.
Infectious Agents and Cancer
|
February 12, 2009
Fear and loathing in the Caribbean: three studies of fear and cancer screening in Brooklyn's immigrant Caribbean subpopulations
Nathan S Consedine, Brenda A Adjei, David Horton, et al.
Leukemia & Lymphoma
|
November 4, 2020
Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
Jonathan Pan, Sushil Ghimire, S Onder Alpdogan, et al.
Nature Communications
|
February 20, 2016
Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
Michael Ramirez, Satwik Rajaram, Robert J Steininger, et al.
Neoplasia (New York, N.Y.)
|
July 18, 2018
Telomerase-Mediated Strategy for Overcoming Non-Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance
Ilgen Mender, Ryan LaRanger, Krishna Luitel, et al.
Page
of 3